Evidence map›Paper›PMID 24039704›Full record

ArticlePloS one2013

Free HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy.

Jayne Byakika-Tusiime, Eric C Polley, Jessica H Oyugi, David R Bangsberg

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jayne Byakika-TusiimeDepartment of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Eric C Polley
Jessica H Oyugi
David R Bangsberg

Funding

TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
University of California, Berkeley (UCB)/University of *D43TW000003 · FIC · UNIVERSITY OF CALIFORNIA BERKELEY · PI REINGOLD, ARTHUR L · 1988 to 2013
$16.7M
Mentoring Patient Oriented Adherence Research in UgandaK24MH087227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BANGSBERG, DAVID ROY · 2009 to 2013
$776k
Antiretviral therapy adherence in resource poor settingR03MH066654 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 2002 to 2003
$151k
FIC NIH HHS 1D43 TW00003FIC NIH HHS D43 TW000003NIMH NIH HHS K24 MH87227NIMH NIH HHS R01 MH54907NIMH NIH HHS R03 MH66654NIMH NIH HHS R21 MH014784
6 · The paper itself

Abstract

objectiveTo estimate the population-level causal effect of source of payment for HIV medication on treatment adherence using Marginal Structural Models.

methodsData were obtained from an observational cohort of 76 HIV-infected individuals with at least 24 weeks of antiretroviral therapy treatment from 2002 to 2007 in Kampala, Uganda. Adherence was the primary outcome and it was measured using the 30-day visual analogue scale. Marginal structural models (MSM) were used to estimate the effect of source of payment for HIV medication on adherence, adjusting for confounding by income, duration on antiretroviral therapy (ART), timing of visit, prior adherence, prior CD4⁺ T cell count and prior plasma HIV RNA. Traditional association models were also examined and the results compared.

resultsFree HIV treatment was associated with a 3.8% improvement in adherence in the marginal structural model, while the traditional statistical models showed a 3.1-3.3% improvement in adherence associated with free HIV treatment.

conclusionRemoving a financial barrier to treatment with ART by providing free HIV treatment appears to significantly improve adherence to antiretroviral therapy. With sufficient information on confounders, MSMs can be used to make robust inferences about causal effects in epidemiologic research.

Indexed as

Medication AdherenceAdultAnti-HIV AgentsCohort StudiesDrug CostsFemaleHealth Care CostsHIV InfectionsHumansMaleMultivariate AnalysisAnti-HIV Agents

Identifiers

PMID24039704
PMCPMC3764136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.